Amrize Ltd (NYSE:AMRZ – Get Free Report) CTO Roald Brouwer acquired 1,500 shares of the firm’s stock in a transaction that occurred on Thursday, May 21st. The stock was purchased at an average cost of $49.84 per share, with a total value of $74,760.00. Following the acquisition, the chief technology officer owned 19,757 shares in the company, valued at $984,688.88. The trade was a 8.22% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Roald Brouwer also recently made the following trade(s):
- On Friday, March 13th, Roald Brouwer acquired 2,000 shares of Amrize stock. The stock was purchased at an average cost of $54.88 per share, with a total value of $109,760.00.
- On Wednesday, March 11th, Roald Brouwer acquired 3,000 shares of Amrize stock. The stock was purchased at an average cost of $58.72 per share, with a total value of $176,160.00.
Amrize Trading Up 1.1%
Shares of AMRZ opened at $50.55 on Friday. The business has a 50-day moving average of $54.95 and a 200 day moving average of $55.12. Amrize Ltd has a fifty-two week low of $44.12 and a fifty-two week high of $65.94. The firm has a market cap of $27.96 billion and a P/E ratio of 24.19. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.89 and a current ratio of 1.40.
Amrize Cuts Dividend
The company also recently announced a dividend, which was paid on Wednesday, May 20th. Investors of record on Tuesday, May 12th were given a $0.11 dividend. The ex-dividend date was Tuesday, May 12th. Amrize’s payout ratio is presently 21.05%.
Institutional Trading of Amrize
Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Vanguard Group Inc. lifted its position in Amrize by 5.6% in the fourth quarter. Vanguard Group Inc. now owns 31,770,926 shares of the company’s stock valued at $1,722,500,000 after purchasing an additional 1,676,843 shares during the last quarter. Norges Bank bought a new stake in Amrize in the fourth quarter valued at approximately $929,333,000. Wellington Management Group LLP lifted its position in Amrize by 48.8% in the third quarter. Wellington Management Group LLP now owns 11,622,024 shares of the company’s stock valued at $561,018,000 after purchasing an additional 3,809,133 shares during the last quarter. Harris Associates L P bought a new stake in Amrize in the fourth quarter valued at approximately $615,406,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank increased its stake in shares of Amrize by 1.6% during the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 9,674,921 shares of the company’s stock valued at $532,076,000 after buying an additional 156,903 shares during the period.
Wall Street Analysts Forecast Growth
A number of analysts recently weighed in on the company. Morgan Stanley restated an “overweight” rating and issued a $65.00 target price on shares of Amrize in a research report on Wednesday, May 6th. Oppenheimer set a $68.00 target price on Amrize in a research report on Friday, May 1st. JPMorgan Chase & Co. boosted their target price on Amrize from $60.00 to $70.00 and gave the stock an “overweight” rating in a research report on Thursday, March 5th. Truist Financial dropped their target price on Amrize from $75.00 to $65.00 and set a “buy” rating for the company in a research report on Friday, May 1st. Finally, Weiss Ratings downgraded Amrize from a “hold (c+)” rating to a “hold (c)” rating in a research report on Monday. One investment analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and six have given a Hold rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $64.86.
Read Our Latest Research Report on Amrize
About Amrize
Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.
See Also
- Five stocks we like better than Amrize
- Biogen Stock Slides After Trial Miss, But Analysts Stay Bullish
- Intuit’s Great SaaS Reset: Fired By AI
- Meta Platforms 10% Layoff Raises a Bigger Question About AI Spending
- As Small-Cap Outperformance Continues, These 2 ETFs Provide Exposure
Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.
